Amgen Inc. buy Royal Bank of Canada
Start price
14.06.24
/
50%
€278.00
Target price
14.06.25
€310.92
Performance (%)
8.07%
Price
12:21
€298.40
Summary
This prediction is currently active. With a performance of 8.07%, the BUY prediction by Royal_Bank_of_Canada for Amgen Inc. is trending in the right direction. Dividends of €2.04 are taken into consideration when calculating the performance. This prediction currently runs until 14.06.25. The prediction end date can be changed by Royal_Bank_of_Canada at any time. Royal_Bank_of_Canada has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Amgen Inc. | 2.054% | 2.054% |
iShares Core DAX® | -0.168% | 4.802% |
iShares Nasdaq 100 | 2.946% | 3.520% |
iShares Nikkei 225® | 1.319% | 6.746% |
iShares S&P 500 | 2.044% | 3.551% |
Comments by Royal_Bank_of_Canada for this prediction
In the thread Amgen Inc. diskutieren
Amgen Inc. (NASDAQ: AMGN) had its price target raised by analysts at Royal Bank of Canada from $328.00 to $332.00. They now have an "outperform" rating on the stock.
Ratings data for AMGN provided by MarketBeat